Hi-Clearance Asset Resilience Ratio

Latest as of September 2025: 2.55%

Hi-Clearance asset resilience ratio. Hi-Clearance (1788) has an Asset Resilience Ratio of 2.55% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Hi-Clearance (1788) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

NT$127.12 Million
≈ $4.00 Million USD Cash + Short-term Investments

Total Assets

NT$4.99 Billion
≈ $157.20 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Hi-Clearance (2016–2024)

Asset resilience ratio of Hi-Clearance from 2016 to 2024. This chart shows how Hi-Clearance's Asset Resilience Ratio has changed over time. Read 1788 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Hi-Clearance's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hi-Clearance assets under control.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents NT$0.00 0%
Short-term Investments NT$127.12 Million 2.55%
Total Liquid Assets NT$127.12 Million 2.55%

Asset Resilience Insights

  • Limited Liquidity: Hi-Clearance maintains only 2.55% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Hi-Clearance Industry Peers by Asset Resilience Ratio

Compare Hi-Clearance's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
HOB Biotech Group Corp Ltd
SHG:688656
Medical Devices 2.62%
L&C Bio Co. Ltd
KQ:290650
Medical Devices 2.14%
Applied BioCode
TW:6598
Medical Devices 9.75%
Oncosil Medical Ltd
AU:OSL
Medical Devices 0.00%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Radiant Innovation
TWO:3373
Medical Devices 0.82%
Impedimed Ltd
AU:IPD
Medical Devices 46.15%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%

Hi-Clearance Asset Resilience Ratio by Year (2016–2024)

Hi-Clearance asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for Hi-Clearance.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.63% NT$130.66 Million
≈ $4.12 Million
NT$4.96 Billion
≈ $156.28 Million
+0.23pp
2023-12-31 2.40% NT$110.86 Million
≈ $3.49 Million
NT$4.62 Billion
≈ $145.49 Million
+0.34pp
2022-12-31 2.06% NT$93.01 Million
≈ $2.93 Million
NT$4.51 Billion
≈ $142.05 Million
+0.72pp
2021-12-31 1.34% NT$59.55 Million
≈ $1.88 Million
NT$4.44 Billion
≈ $139.80 Million
-0.12pp
2020-12-31 1.47% NT$61.65 Million
≈ $1.94 Million
NT$4.20 Billion
≈ $132.42 Million
-0.55pp
2019-12-31 2.01% NT$75.07 Million
≈ $2.37 Million
NT$3.73 Billion
≈ $117.42 Million
-2.36pp
2018-12-31 4.38% NT$129.95 Million
≈ $4.09 Million
NT$2.97 Billion
≈ $93.55 Million
-1.10pp
2017-12-31 5.48% NT$143.14 Million
≈ $4.51 Million
NT$2.61 Billion
≈ $82.33 Million
-1.20pp
2016-12-31 6.68% NT$165.10 Million
≈ $5.20 Million
NT$2.47 Billion
≈ $77.85 Million
--
pp = percentage points

About Hi-Clearance

TWO:1788 Taiwan Medical Devices
Market Cap
$177.44 Million
NT$5.63 Billion TWD
Market Cap Rank
#16815 Global
#825 in Taiwan
Share Price
NT$126.50
Change (1 day)
-0.39%
52-Week Range
NT$126.50 - NT$138.00
All Time High
NT$149.30
About

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumabl… Read more